Because no studies have indicated CADM1 expression in CD4 lymphocytes in chronic inflammatory diseases such as RA, it is unclear whether HAS-Flow is an adequate method to evaluate HTLV-1-infected cells and ATL development in HTLV-1-positive RA patients. This evidence concerns the gene CD4 and rheumatoid arthritis.